Wednesday, 20 March 2013

New Report Warns of Diabetes Epidemic in India

India with over 63 million diabetics represents the world’s second largest diabetes population after China. The Indian population that had faced under nutrition for a long time is now exposed to over nutrition and sedentary lifestyles. Coupled with a bad nutritional history and the fact that Indians are genetically more vulnerable to diabetes compared to other population groups, India’s struggle with diabetes is expected to be one of the biggest epidemics the country has ever witnessed. 

India’s diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in the healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.


IMARC’s new report- “Indian Diabetes Market Report: Epidemiology, Patients, Prevalence, Oral Anti-diabetics, Insulin and Diagnostics”, provides an analytical and statistical insight into the Indian diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in India. The report has segmented the Indian diabetes market into three segments - Oral Anti-diabetics, Insulin and DiabetesDiagnostics. For each of the aforementioned categories, the report provides historical and future market sales, performance of key classes and the performance of top players. 

The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Indian diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Indian diabetes market in some form or the other.


What we have achieved in this report:

Comprehensive situation analysis of the Indian diabetes epidemiology and its dynamics:

Focus of the Analysis:
•Historical, current and future prevalence of diabetes in India 
•Historical, current and future prevalence of type-1 and type-2 diabetes in India
•Historical, current and future prevalence of diabetes in the urban and rural regions in India
•Historical, current and future prevalence of diabetes among males and females in India
•Historical, current and future prevalence of diabetes among various age groups in India
•Historical, current and future diagnosis rates for diabetes in India
•Historical, current and future drug treatment rates for diabetes in India

Comprehensive situation analysis of the Indian Oral Anti-diabetics market and its dynamics:

Focus of the Analysis:
•Performance of the Oral Anti-diabetics market in India
•Performance of key classes
•Performance of key players
•Market outlook

Comprehensive situation analysis of the Indian Insulin market and its dynamics:

Focus of the Analysis:
•Performance of the Insulin market in India
•Performance of key classes
•Performance of key players
•Market outlook

Comprehensive situation analysis of the diabetes diagnostics market and its dynamics:

Focus of the Analysis:
•Performance of the diabetes diagnostics market in India
•Performance of key classes
•Performance of key players
•Market outlook

Information Sources:

Information has been sourced from both primary and secondary sources:

•Primary sources include industry surveys and face to face/telephone interviews with physicians and industry experts.
•Secondary sources include proprietary databases and search engines. These sources include company websites, reports, books, trade journals, magazines, white papers, Industry Portals, government sources and access to more than 4000 paid databases.

Forecasting Methodology:
IMARC generates its product and market forecasts utilizing its extensive database of macroeconomic and sector specific data. The initial baseline forecast is generated with the most recent market data. After an initial baseline forecast, all future macroeconomic and sector specific events and assumptions are taken into account to generate the final forecast.

Table of Contents
1 Research Methodology
2 Executive Summary
3 Diabetes Disease Overview
3.1 What is Diabetes?
3.2 Diabetes Diagnosis and Treatment
3.2.1 Diagnosis
3.2.2 Treatment
3.3 Diabetes Complications
4 Factors Driving the Diabetes Market in India
4.1 Increasing Obesity Levels
4.2 Urbanization
4.3 India has the Second Largest Diabetes Patient Base in the World
4.4 India Represents One of the Fastest Growing Markets Globally
4.5 Improving Diagnosis and Treatment Rates
5 The Indian Diabetes Epidemiology
5.1 Diabetes Population and Prevalence Rates
5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
5.3 Population and Prevalence Rates by Region (Urban and Rural)
5.4 Population and Prevalence Rates by Gender
5.5 Population and Prevalence Rates by Age Group
5.6 Diabetes Diagnosis and Drug Treatment Rates
6 Indian Diabetes Market
6.1 Historical Market Trends (2005-2012)
6.2 Market Breakup by Segment (2005-2012)
6.3 The Indian Oral Anti-diabetics Market
6.3.1 Historical Market Trends (2005-2012)
6.3.2 Market Breakup by Class (2005-2012)
6.3.3 Market Shares of Key Players
6.3.4 Market Outlook (2013-2018)
6.4 The Indian Insulin Market
6.4.1 Historical Market Trends (2005-2012)
6.4.2 Market Breakup by Class
6.4.3 Market Shares of Key Players
6.4.4 Market Outlook (2013-2018)
6.5 Market Outlook (2013-2018)
7 Indian Diabetes Diagnostics Market
7.1.1 Historical Market Trends (2005-2012)
7.1.2 Market Segmentation
7.1.3 Market Shares of Key Players
7.1.4 Market Outlook (2012-2017)



To buy the complete report or to get a free sample, please contact:

IMARC Group Asia
Email: apac@imarcgroup.com
Phone: +91-120-415-5099

IMARC Group North America 
Email: america@imarcgroup.com
Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa
Email:ema@imarcgroup.com
Phone: +44-702-409-7331


For more information, visit: http://www.imarcgroup.com/indian-diabetes-market-report-epidemiology-patients-prevalence-oral-anti-diabetics-insulin-and-diagnostics/

Tuesday, 19 March 2013

Processed Food Market in India Yet to be Tapped

The growth of the organized retail market, rising disposable incomes, urbanization, large working population, etc., are expected to be the catalysts in driving the Indian processed food market in the coming years. Research firm IMARC Group expects this market to grow at a CAGR of around 11% during 2012-13 – 2017-18, according to its new report titled “Indian Agriculture Market Report & Forecast: 2012-2017”. The report that has done a comprehensive analysis on the Indian agriculturemarket finds that only around 6% of the total food-items produced in India are currently processed. This is significantly lower than the 60-80% of the total food items processed in the developed nations. This suggests that the market still remains largely unpenetrated.

IMARC’s new report entitled “Indian Agriculture Market Report & Forecast: 2012-2017” provides an analytical and statistical insight into the agriculture industry along with its various segments and sub-segments. The study that has been undertaken using both desk-based and qualitative primary research has analyzed various aspects and provides a comprehensive understanding of the Indian agriculture market. The report can serve as an excellent guide for investors, researchers, consultants, marketing strategists, and all those who are looking to foray into the Indian agriculturemarket in some form or the other.


What We Have Achieved in this Report 
• Comprehensive situation analysis of the Indian agriculture market and its dynamics.
• Identifying all application segments/sub-segments and quantifying their current and future market potential.
• Providing robust long range value and volume forecasts for all segments and sub-segments.
• Providing an understanding of key drivers and restraints and their impact on current and future market scenario.

Agricultural Segments Covered in this Report
• Farming
• Agriculture Equipments
• Fertilizers
• Pesticides
• Warehousing
• Cold Chains
• Food Processing
• Dairy Farming
• Floriculture
• Apiculture
• Sericulture
• Seeds 
• Fisheries
• Poultry
• Animal Husbandry

Focus of the Analysis for Each Segment and Sub-Segment
• Drivers and Challenges
• Historical, Current and Future Market Values
• Historical, Current and Future Market Volumes
• Analysis of Various Sub-Segments
• Areas of Opportunity
• Competitive Landscape
Information Sources

Information has been gleaned from both primary and secondary sources:
• Primary sources include industry surveys and face to face/telephone interviews with industry experts.
• Secondary sources include proprietary databases and search engines. These sources include company websites and reports, books, trade journals, magazines, white papers, industry portals, government sources and access to more than 4000 paid databases.

To buy the complete report or to get a free sample, please contact:

IMARC Group Asia
Email: apac@imarcgroup.com
Phone: +91-120-415-5099

IMARC Group North America 
Email: america@imarcgroup.com
Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa
Email:ema@imarcgroup.com
Phone: +44-702-409-7331

To know more please visit: http://www.imarcgroup.com/indian-agriculture-market-report-forecast-2012-2017-3/

Monday, 18 March 2013

Biotech Growth to Slow Down in the US

A new report from IMARC Group expects the biopharmaceutical market in the US to grow at a CAGR of around 5% during 2012-2017. This is significantly lower than the average 8-9% growth rate observed in this market in the last five years. 

According to an analyst at IMARC Group, “the rise of biosimilars in the US is expected to have a major impact on market growth. Recombinant proteins, which currently account for around 60% of the total US biopharmaceutical sales, are expected to be the worst hit during the forecast period. During 2012-2017, we expect nine biological brands in this segment to face biosimilar competition. Recombinant proteins are expected to witness a CAGR growth of less than 3% during this period. The growth of monoclonal antibodies, on the other hand, is expected to be significantly faster than recombinant proteins during the forecast period. The key factors driving the monoclonal antibodieswill be a rich pipeline and approval of additional indications for currently marketed drugs. Although some monoclonal antibodies such as Rituxan and Humira may face biosimilar competition, we expect significantly lower biosimilar threat for monoclonal antibodies during the forecast period compared to recombinant proteins.

IMARC’s new report “Global Biopharmaceutical Market Report & Forecast (2012-2017)” gives a deep insight into the global biopharmaceutical market. The research study serves as an analytical as well as a statistical tool to understand the strengths, weaknesses, opportunities, threats, market trends, geographical structure, therapeutic structure, competitive structure and the outlook of the global biopharmaceutical market till 2017. This report will serve as an excellent guide for investors, researchers, consultants, marketing strategists, and all those who are planning to foray into the global biopharmaceutical market in any form. 

What We Have Achieved in this Report?

Deep Qualitative Understanding of Various Factors Driving and Restraining the Global Biopharmaceutical Market
Key Aspects Analyzed:
• Driving Factors 
• Restraining Factors
• Market Opportunities
• Threats

Comprehensive Situation Analysis of the Global Biopharmaceutical Market and its Dynamics
Regions/Countries Covered:
North America: United States and Canada
Latin America: Mexico, Brazil and Argentina
Europe: Germany, France, Italy, Spain, United Kingdom, Russia and Turkey
Asia Pacific: Japan, China, Australia, South Korea, India and Indonesia

Classes Covered for Each Country: Erythropoietins, Insulin, Interferons, Growth Hormones, Immunoglobulins, Colony Stimulating Factors, Recombinant Blood Factors, Recombinant Enzymes, Growth Factors, Interleukins, Monoclonal Antibodies and Purified Proteins

Focus of the Analysis for Each Country: 
• Total Market Performance (2005 - 2011)
Performance of Various Classes (2005 - 2011)
Performance of Top Players (2005 - 2011)
• Market Forecast (2012 - 2017)

Key Questions Answered in this Report:
• What are the key advantages/ disadvantages of biopharmaceuticals over small molecule drugs in terms of efficacy, safety, price, approval times, market growth, etc.?
• What are the key opportunities and threats faced by the biopharmaceutical industry?
• What has been the historical and current performance of the global biopharmaceutical market and how is it expected to perform in the coming years?
• Which are the world’s largest biopharmaceutical markets?
• Which are the world’s fastest growing biopharmaceutical markets?
• What is the structure and composition of various biopharmaceutical markets across the globe?
• Which are the world’s largest biopharmaceutical segments?
• Which are the world’s fastest growing biopharmaceutical segments?
• Who are the world’s largest biopharmaceutical companies and how have they performed in recent years?


To buy the complete report or to get a free sample, please contact:

IMARC Group Asia
Email: apac@imarcgroup.com
Phone: +91-120-415-5099

IMARC Group North America 
Email: america@imarcgroup.com
Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa
Email:ema@imarcgroup.com
Phone: +44-702-409-7331


To know more please visit: http://www.imarcgroup.com/global-biopharmaceutica-market-report-forecasts-2012-2017/

Thursday, 14 March 2013

Global Sorbitol Demand to Reach 2.5 Million Mt by 2017

A new report released by IMARC Group expects the global demand for sorbitol to grow at a CAGR of 2% during 2012-2017, reaching volumes worth 2.5 Million Mt by 2017. The report entitled “Global Sorbitol (Glucitol) Market Report & Forecast: Market Size, Share, Growth, Production Capacity, Price, Applications, Feedstocks, Manufacturers and Forecast: 2013-2017” provides an analytical and statistical insight into the global sorbitol market. The study, that has been undertaken using desk-based as well as qualitative primary research, provides a comprehensive analysis of the global sorbitol market.

What we have achieved in this report:

Comprehensive situation analysis of the global sorbitol market and its dynamics
Focus of the analysis:
• Historical, current and future trends in production capacity
• Historical, current and future trends in production
• Historical, current and future trends in demand
• Historical, current and future trends in prices
• Demand by application sector
• Production capacity by region
• Production by region
• Consumption by region
• Production by type of feedstock (corn, wheat, cassava, etc.)
• Key players and their production capacities
• Sorbitol substitutes

Evaluation of major regions
Regions covered: China, United States, Western Europe, Indonesia and India
Focus of the analysis for each region:
• Historical, current and future trends in production capacity
• Historical, current and future trends in production
• Historical, current and future trends in demand
• Historical, current and future trends in prices
• Demand by application sector
• Production capacity by region

Evaluation of various sorbitol feedstocks and manufacturing process
Focus of the analysis:
• Characteristics of various feedstocks used in sorbitol production
• Yield of sorbitol and byproducts from various feedstocks
• Supply and demand of various feedstocks
• Manufacturing process of sorbitol
• Interchanging feedstocks

Evaluation of major sorbitol manufacturers
Manufacturers covered: Roquette Frères, Cargill, Ingredion, Archer Daniels Midland, Shandong Tianli, PT Sorini, Nikken Fine Chemicals, Global Sweeteners Holdings and Khalista (Liuzhou) Chemical Industries.
Focus of the analysis:
• Company description
• Sorbitol production capacity
• Sorbitol production
• Feedstocks used for sorbitol production
• Plant locations and their capacities

Information Sources
Information has been sourced from both primary and secondary sources:
• Primary sources include industry surveys and face to face/telephone interviews with manufacturers, end-users and industry experts.
• Secondary sources include proprietary databases and search engines. These sources include company websites, reports, books, trade journals, magazines, white papers, industry portals, government sources and access to more than 4000 paid databases.

To buy the complete report or to get a free sample, please contact:

IMARC Group Asia
Email: apac@imarcgroup.com
Phone: +91-120-415-5099

IMARC Group North America 
Email: america@imarcgroup.com
Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa
Email:ema@imarcgroup.com
Phone: +44-702-409-7331

To know more please visit: http://www.imarcgroup.com/global-sorbitol-glucitol-market-report-forecast-market-size-share-growth-production-capacity-price-applications-feedstocks-manufacturers-and-forecast-2013-2017/

Increasing Globalization Trends Driving the Market for Clinical Trial Cold Chain Services

Driven by an increased spending and globalization of clinical trials, the demand for efficient storage and transportation services for clinical trial materials has increased significantly over the past few years. Research firm IMARC Group expects this market to grow at a CAGR of around 4% during 2012-2016, according to its latest report titled “Global Healthcare Cold Chain Logistics Market Report & Forecast: 2012-2017”. According to an analyst at IMARC Group, “the increasing trends in clinical trials outsourcing is creating additional steps in the overall supply chain of clinical trial materials (drugs, blood samples, tissue samples, urine samples, sputum samples, etc). In many cases contract research organizations and their sponsors may be present in two different countries, this is quite evident from the fact that the number of clinical trials in many Asian, Latin American and East European countries are increasing rapidly whereas the sponsors are based in the US and Western Europe. The large distance creates huge requirements for the efficient cold chain packaging, storage and transportation of clinical trial materials between the clinical trial sponsor and the contract research organization”. 

This report, an updated and far more extensive and analytical version of our popular 2011 study, provides a comprehensive insight into the logistic opportunities in the global healthcare market. The study, that has been undertaken using both desk based and qualitative primary market research, has analyzed three aspects of the global healthcare cold chain logistics market.


The first aspect involves the quantification of the global market for temperature sensitive healthcare products into three major classes and evaluation of the current and future opportunities in each of these classes. The second aspect involves an in-depth understanding on the global healthcare cold chain distribution process and logistic requirements for various temperature sensitive healthcare products. The third aspect involves the quantification of the global healthcare cold chain logistic services market and a comprehensive evaluation of its various segments.

What we have achieved in this report:

Comprehensive Market Analysis of Temperature Sensitive Healthcare Products:
Classes Covered: Biopharmaceuticals, Vaccines & Clinical Trial Materials 
Focus of the Analysis in Each Class:
• Drivers and challenges 
• Historical sales trends
• Logistic requirements 
• Impact of temperature excursions 
• Opportunities in cold chain services
• Market outlook (2012-2017)

Understanding the Operations of a Healthcare Cold Chain Distribution Process
Focus of the Analysis:
• Understanding the various methods of cold chain distribution and their advantages/disadvantages
• Understanding the cold chain requirements for various temperature sensitive healthcare products and the impact of temperature excursions
• Understanding the various costs involved in cold chain transportation and comparing it with non-cold chain transportation
• Understanding the key steps required in the setting and organization of an efficient cold chain distribution process

Comprehensive Market Analysis of the Healthcare Cold Chain Logistic Services Market:
Focus of the analysis:
• Quantifying the global healthcare cold chain logistic services market
• Quantifying the market size by product
• Quantifying the market size by service
• Quantifying the market size by region

Information Sources:
Information has been sourced from both primary and secondary sources:
• Primary sources include industry surveys and face to face/telephone interviews with industry experts.
• Secondary sources include proprietary databases and search engines. These sources include company websites and reports, books, trade journals, magazines, white papers, industry portals, government sources and access to more than 4000 paid databases.


To buy the complete report or to get a free sample, please contact:

IMARC Group Asia
Email: apac@imarcgroup.com
Phone: +91-120-415-5099

IMARC Group North America 
Email: america@imarcgroup.com
Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa
Email:ema@imarcgroup.com
Phone: +44-702-409-7331


For more information, visit: http://www.imarcgroup.com/global-healthcare-cold-chain-logistics-market-report-forecast-2012-2017/

Tuesday, 12 March 2013

The Market for Flavoured Milk Witnessing Strong Growth in India

With Indian consumers slowly moving from carbonated soft drinks to healthier options, flavoured milk represents one of the fastest growing segments in the Indian dairy market. Research firm IMARC Group expects this market to grow at a CAGR of around 21% during 2012-2016, according to its latest report titled “Indian Dairy Market Report & Forecast: 2012-2016”. According to an analyst at IMARC Group, “The flavoured milk segment comes into the ready to drink beverage class. With increasing urbanization and sedentary lifestyles, the ready to drink flavoured milk segment represents a very convenient option for the Indian middle class where there are no hassles to boil, add external ingredients or serve this milk. Moreover, the advent of single-serve, resealable plastic bottles or tetra packs have made this category of milk more convenient for consumers to drink and easier for distributors to ship”. 

Apart from the convenience factor, the flavoured milk category is also driven by an increasing trend of Indian consumers shifting towards the health and wellness segment. The flavoured milk segment is one that is driven by the well-to-do income class, where consumers are shifting from carbonated drinks to natural and nutritious drinks such as juices and dairy products. Driven by this trend, manufacturers of flavoured drinks are continuously innovating their products in such a way so that they appeal to consumers both in terms of nutritious value as well as taste.


This study, an updated and far more extensive and analytical version of our popular 2011 study, provides and draws upon a comprehensive analysis of every major dairy segment in India. The study, which has been undertaken using both desk research and two waves of qualitative primary research, has analyzed three aspects of the Indian dairy market.

The first section quantifies the Indian dairy market into fifteen major segments and investigates the current and future opportunities in each of these segments. The second section provides an in-depth understanding of dairy consumption patterns among Indian consumers and the potential of value added dairy products. The third section investigates into the usage of natural colouration in dairy products and evaluates their current and future potential. 

What we have achieved in this report:

• Comprehensive situation analysis of the Indian dairy market and its dynamics: 

Segments covered: Milk, UHT Milk, Curd, Butter, Ghee, Paneer, Cheese, Khoya, Skimmed Milk Powder, Flavoured Milk, Tea, Coffee, Dairy Whiteners, Infant Nutrition, Malt Beverages and Ice Cream

Focus of the analysis in each Class:
• Drivers and challenges in each market
• Historical, current & future sales trends (2006 - 2017)
• Historical, current & future volume trends (2006 - 2017)
• Historical, current & future price trends (2006 - 2017)
• Size and analysis of the organized and unorganized markets
• Structure of the market
• Key players and products available in these markets

• Understanding the dairy consumption patterns of Indian consumers and evaluating the potential of value added products:

In order to gain an insight into the awareness and acceptance levels of value added dairy products, IMARC Conducted in-depth interviews with Industry experts and consumers in major metropolitan and tier-1 cities in India

Focus of the analysis:
• Buying behavior
• Price sensitivity
• Nutritional requirements
• Consumer awareness of value added products
• Brand loyalty and switching trends
• Potential of value added dairy products in India

• Understanding the current landscape of natural colouration in dairy products

Classes Covered: Butter, Cheese, Yoghurt, Margarine, Flavored Milk and Ice Cream

Focus of the analysis:
• Size of the natural colouration market in India
• Key drivers and challenges in the market
• Usage of natural colouration in dairy products 

Information Sources:
Information has been sourced from both primary and secondary sources:
• Primary sources include industry surveys and face to face/telephone interviews with consumers and industry experts.
• Secondary sources include proprietary databases and search engines. These sources include company websites and reports, books, trade journals, magazines, white papers, industry portals, government sources and access to more than 4000 paid databases.


To buy the complete report or to get a free sample, please contact:

IMARC Group Asia
Email: apac@imarcgroup.com
Phone: +91-120-415-5099

IMARC Group North America 
Email: america@imarcgroup.com
Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa
Email:ema@imarcgroup.com
Phone: +44-702-409-7331


For more information, visit: http://www.imarcgroup.com/indian-dairy-market-report-forecasts/